Provide active pharmaceutical ingredients (APIs) and concentrations, dosage form (cream, gel, patch), batch size, primary packaging specifications (e.g., aluminum tubes), target market regulatory standards, and destination.
Category market report
Dermatological Drugs
Total suppliers
7,274+
Total Chinese suppliers export
$11.3B+
Recommended
High-quality suppliers related to Dermatological Drugs.
Suppliers
Find more suppliers who may be worth contacting.
Top suppliers
Suppliers in this category.
- Transactions
1,897
2018-012022-032026-08Transaction trend for Astrazeneca Pharmaceutical Co., Ltd.
- 2018-01: 4
- 2018-02: 2
- 2018-03: 3
- 2018-04: 4
- 2018-05: 3
- 2018-06: 10
- 2018-07: 5
- 2018-09: 10
- 2018-10: 2
- 2018-11: 1
- 2018-12: 1
- 2019-01: 32
- 2019-02: 19
- 2019-03: 17
- 2019-04: 13
- 2019-05: 19
- 2019-06: 16
- 2019-07: 9
- 2019-08: 5
- 2019-09: 4
- 2019-10: 7
- 2019-11: 13
- 2019-12: 15
- 2020-01: 24
- 2020-02: 1
- 2020-03: 18
- 2020-04: 30
- 2020-05: 27
- 2020-06: 14
- 2020-07: 13
- 2020-08: 38
- 2020-09: 4
- 2020-10: 21
- 2020-11: 28
- 2020-12: 16
- 2021-01: 9
- 2021-02: 42
- 2021-03: 23
- 2021-04: 20
- 2021-05: 44
- 2021-06: 23
- 2021-07: 19
- 2021-08: 33
- 2021-09: 15
- 2021-10: 46
- 2021-11: 27
- 2021-12: 22
- 2022-01: 43
- 2022-02: 9
- 2022-03: 22
- 2022-04: 30
- 2022-05: 24
- 2022-06: 26
- 2022-07: 19
- 2022-08: 18
- 2022-09: 19
- 2022-10: 34
- 2022-11: 12
- 2022-12: 37
- 2023-01: 13
- 2023-02: 19
- 2023-03: 51
- 2023-04: 22
- 2023-05: 12
- 2023-06: 26
- 2023-07: 23
- 2023-08: 17
- 2023-09: 45
- 2023-10: 10
- 2023-11: 32
- 2023-12: 15
- 2024-02: 28
- 2024-03: 12
- 2024-05: 31
- 2024-06: 18
- 2024-07: 16
- 2024-08: 6
- 2024-09: 15
- 2024-10: 16
- 2024-11: 11
- 2024-12: 14
- 2025-01: 21
- 2025-02: 14
- 2025-03: 19
- 2025-04: 13
- 2025-05: 9
- 2025-06: 11
- 2025-07: 20
- 2025-08: 17
- 2025-09: 13
- 2025-10: 7
- 2025-11: 13
- 2025-12: 16
- 2026-01: 21
- 2026-03: 13
- 2026-04: 49
- 2026-05: 34
- 2026-06: 28
- 2026-07: 28
- 2026-08: 14
- Amount
4,100,621.13
2018-012022-032026-08Amount trend for Astrazeneca Pharmaceutical Co., Ltd.
- 2018-01: 19.5M
- 2018-02: 23.3K
- 2018-03: 613.5K
- 2018-04: 401K
- 2018-05: 53.6K
- 2018-06: 195.8K
- 2018-07: 174.2K
- 2018-09: 1.4M
- 2018-10: 143.4K
- 2018-11: 27.6K
- 2018-12: 23K
- 2019-01: 40.7B
- 2019-02: 2.8M
- 2019-03: 2.4M
- 2019-04: 1.7M
- 2019-05: 2.6M
- 2019-06: 3.1M
- 2019-07: 1.8M
- 2019-08: 840.4K
- 2019-09: 772.1K
- 2019-10: 2.5M
- 2019-11: 2M
- 2019-12: 1.8M
- 2020-01: 7M
- 2020-02: 9,942.19
- 2020-03: 3.1M
- 2020-04: 4.1M
- 2020-05: 4.5M
- 2020-06: 5.9M
- 2020-07: 2.1M
- 2020-08: 7.6M
- 2020-09: 281.4K
- 2020-10: 1.8M
- 2020-11: 2.3M
- 2020-12: 2.1M
- 2021-01: 927.7K
- 2021-02: 5.9M
- 2021-03: 3M
- 2021-04: 2.8M
- 2021-05: 6.3M
- 2021-06: 4.1M
- 2021-07: 2.5M
- 2021-08: 4M
- 2021-09: 3.4M
- 2021-10: 7M
- 2021-11: 3.9M
- 2021-12: 4M
- 2022-01: 8.5M
- 2022-02: 2.3M
- 2022-03: 2.2M
- 2022-04: 5.2M
- 2022-05: 2.8M
- 2022-06: 4.1M
- 2022-07: 3.3M
- 2022-08: 2.1M
- 2022-09: 2.8M
- 2022-10: 5.3M
- 2022-11: 2M
- 2022-12: 5.9M
- 2023-01: 1.2M
- 2023-02: 3.3M
- 2023-03: 6.5M
- 2023-04: 3.4M
- 2023-05: 3.1M
- 2023-06: 3.4M
- 2023-07: 2.5M
- 2023-08: 2.8M
- 2023-09: 6.7M
- 2023-10: 1.9M
- 2023-11: 5.4M
- 2023-12: 3.1M
- 2024-02: 8.1M
- 2024-03: 3.1M
- 2024-05: 5.5M
- 2024-06: 3.3M
- 2024-07: 3M
- 2024-08: 1.3M
- 2024-09: 2.5M
- 2024-10: 2.2M
- 2024-11: 2M
- 2024-12: 1.8M
- 2025-01: 4.7M
- 2025-02: 1M
- 2025-03: 2.5M
- 2025-04: 2.9M
- 2025-05: 2.5M
- 2025-06: 1.9M
- 2025-07: 3M
- 2025-08: 1.3M
- 2025-09: 2.8M
- 2025-10: 661.9K
- 2025-11: 2M
- 2025-12: 3.1M
- 2026-01: 1.9M
- 2026-03: 697.5K
- 2026-04: 3.1M
- 2026-05: 1.7M
- 2026-06: 1.4M
- 2026-07: 799.3K
- 2026-08: 117.8K
- Main export countries
- India (0.6%)
- Sri Lanka (0%)
- Namibia (0%)
- Mexico (99.3%)
- Transactions
231
2018-012021-052025-08Transaction trend for Zoetis Suzhou Mfg Co., Ltd.
- 2018-01: 4
- 2018-02: 3
- 2018-03: 4
- 2018-04: 1
- 2018-05: 2
- 2018-06: 4
- 2018-07: 1
- 2018-09: 4
- 2018-11: 2
- 2018-12: 3
- 2019-01: 9
- 2019-02: 4
- 2019-03: 3
- 2019-04: 7
- 2019-05: 8
- 2019-06: 3
- 2019-07: 7
- 2019-08: 4
- 2019-09: 1
- 2019-10: 5
- 2019-11: 7
- 2020-01: 2
- 2020-03: 2
- 2020-04: 7
- 2020-05: 7
- 2020-06: 4
- 2020-09: 4
- 2020-11: 7
- 2021-03: 2
- 2021-04: 1
- 2021-05: 10
- 2021-06: 3
- 2021-07: 2
- 2021-09: 2
- 2021-10: 2
- 2021-11: 2
- 2022-04: 2
- 2022-05: 2
- 2022-07: 2
- 2022-10: 2
- 2022-11: 4
- 2022-12: 1
- 2023-03: 1
- 2023-04: 2
- 2023-06: 2
- 2023-09: 4
- 2024-01: 1
- 2024-04: 5
- 2024-05: 13
- 2024-06: 10
- 2024-07: 4
- 2024-08: 5
- 2024-09: 3
- 2024-10: 6
- 2024-11: 8
- 2024-12: 2
- 2025-01: 2
- 2025-02: 1
- 2025-03: 1
- 2025-04: 1
- 2025-05: 3
- 2025-08: 1
- Amount
564,082.25
2018-012021-052025-08Amount trend for Zoetis Suzhou Mfg Co., Ltd.
- 2018-01: 2.4M
- 2018-02: 788K
- 2018-03: 1.2M
- 2018-04: 3.2M
- 2018-05: 95.9K
- 2018-06: 941K
- 2018-07: 13.3M
- 2018-09: 1.3M
- 2018-11: 2M
- 2018-12: 1.8M
- 2019-01: 5.5B
- 2019-02: 273.6K
- 2019-03: 292.8K
- 2019-04: 648.4K
- 2019-05: 2.9M
- 2019-06: 2.1M
- 2019-07: 6.3M
- 2019-08: 3.3M
- 2019-09: 94.7K
- 2019-10: 465.6K
- 2019-11: 617.2K
- 2020-01: 108.3K
- 2020-03: 165.6K
- 2020-04: 437.4K
- 2020-05: 503.9K
- 2020-06: 169K
- 2020-09: 352K
- 2020-11: 629.8K
- 2021-03: 180.9K
- 2021-04: 27.6K
- 2021-05: 709.9K
- 2021-06: 431.7K
- 2021-07: 64K
- 2021-09: 28K
- 2021-10: 3.2M
- 2021-11: 4.3M
- 2022-04: 83.1K
- 2022-05: 72.9K
- 2022-07: 4.7M
- 2022-10: 2.3M
- 2022-11: 4.3M
- 2022-12: 30.7K
- 2023-03: 4.1M
- 2023-04: 80.3K
- 2023-06: 7.5M
- 2023-09: 240.3K
- 2024-01: 0
- 2024-04: 4.6M
- 2024-05: 112K
- 2024-06: 2.4M
- 2024-07: 242.3K
- 2024-08: 9.7M
- 2024-09: 268.5K
- 2024-10: 8.3M
- 2024-11: 13.4M
- 2024-12: 431.2K
- 2025-01: 124.8K
- 2025-02: 193.3K
- 2025-03: 193.9K
- 2025-04: 64.6K
- 2025-05: 10.9M
- 2025-08: 36.7K
- Main export countries
- Peru (0.5%)
- Indonesia (97.8%)
- United States (0.9%)
- Not available (0.9%)
- Transactions
47
2019-012020-102021-09Transaction trend for Puyang Hotway Pharmacy Co., Ltd.
- 2019-01: 32
- 2019-11: 2
- 2020-04: 2
- 2020-05: 1
- 2020-06: 1
- 2020-10: 1
- 2021-03: 2
- 2021-04: 1
- 2021-05: 1
- 2021-07: 1
- 2021-08: 1
- 2021-09: 2
- Amount
559,462.81
2019-012020-102021-09Amount trend for Puyang Hotway Pharmacy Co., Ltd.
- 2019-01: 5.6B
- 2019-11: 24.9K
- 2020-04: 22.1K
- 2020-05: 11.8K
- 2020-06: 12.3K
- 2020-10: 11.9K
- 2021-03: 24.6K
- 2021-04: 12.5K
- 2021-05: 12.7K
- 2021-07: 12.5K
- 2021-08: 12.5K
- 2021-09: 25.3K
- Main export countries
- Indonesia (100%)
Intelligence
China export momentum, destination markets, and regional demand.
China export trend
China export trend
- Date 2018-07: Value 3.5B USD
- Date 2018-08: Value 3.4B USD
- Date 2018-09: Value 3.1B USD
- Date 2018-10: Value 3.2B USD
- Date 2018-11: Value 3.8B USD
- Date 2018-12: Value 3.8B USD
- Date 2019-01: Value 3.7B USD
- Date 2019-02: Value 2.4B USD
- Date 2019-03: Value 3.7B USD
- Date 2019-04: Value 4B USD
- Date 2019-05: Value 4.4B USD
- Date 2019-06: Value 3.7B USD
- Date 2019-07: Value 4.1B USD
- Date 2019-08: Value 4B USD
- Date 2019-09: Value 3.9B USD
- Date 2019-10: Value 4.2B USD
- Date 2019-11: Value 4.6B USD
- Date 2019-12: Value 4.8B USD
- Date 2020-01: Value 0 USD
- Date 2020-02: Value 6.8B USD
- Date 2020-03: Value 5.1B USD
- Date 2020-04: Value 4.6B USD
- Date 2020-05: Value 3.9B USD
- Date 2020-06: Value 0 USD
- Date 2020-07: Value 0 USD
- Date 2020-08: Value 0 USD
- Date 2020-09: Value 4.3B USD
- Date 2020-10: Value 3.3B USD
- Date 2020-11: Value 3.8B USD
- Date 2020-12: Value 3.5B USD
- Date 2021-01: Value 224M USD
- Date 2021-02: Value 195M USD
- Date 2021-03: Value 237M USD
- Date 2021-04: Value 246M USD
- Date 2021-05: Value 225M USD
- Date 2021-06: Value 225M USD
- Date 2021-07: Value 252M USD
- Date 2021-08: Value 222M USD
- Date 2021-09: Value 260M USD
- Date 2021-10: Value 258M USD
- Date 2021-11: Value 263M USD
- Date 2021-12: Value 289M USD
- Date 2022-01: Value 285M USD
- Date 2022-02: Value 210M USD
- Date 2022-03: Value 303M USD
- Date 2022-04: Value 257M USD
- Date 2022-05: Value 279M USD
- Date 2022-06: Value 263M USD
- Date 2022-07: Value 277M USD
- Date 2022-08: Value 269M USD
- Date 2022-09: Value 261M USD
- Date 2022-10: Value 234M USD
- Date 2022-11: Value 281M USD
- Date 2022-12: Value 241M USD
- Date 2023-01: Value 230M USD
- Date 2023-02: Value 211M USD
- Date 2023-03: Value 264M USD
- Date 2023-04: Value 245M USD
- Date 2023-05: Value 282M USD
- Date 2023-06: Value 264M USD
- Date 2023-07: Value 225M USD
- Date 2023-08: Value 260M USD
- Date 2023-09: Value 269M USD
- Date 2023-10: Value 204M USD
- Date 2023-11: Value 249M USD
- Date 2023-12: Value 279M USD
- Date 2024-01: Value 377M USD
- Date 2024-02: Value 253M USD
- Date 2024-03: Value 348M USD
- Date 2024-04: Value 314M USD
- Date 2024-05: Value 263M USD
- Date 2024-06: Value 372M USD
- Date 2024-07: Value 335M USD
- Date 2024-08: Value 354M USD
- Date 2024-09: Value 326M USD
- Date 2024-10: Value 314M USD
- Date 2024-11: Value 356M USD
- Date 2024-12: Value 421M USD
- Date 2025-01: Value 394M USD
- Date 2025-02: Value 265M USD
- Date 2025-03: Value 367M USD
- Date 2025-04: Value 362M USD
- Date 2025-05: Value 356M USD
- Date 2025-06: Value 367M USD
- Date 2025-07: Value 387M USD
- Date 2025-08: Value 354M USD
- Date 2025-09: Value 370M USD
- Date 2025-10: Value 253M USD
- Date 2025-11: Value 394M USD
- Date 2025-12: Value 394M USD
- Date 2026-01: Value 421M USD
- Date 2026-02: Value 299M USD
- Date 2026-03: Value 352M USD
- Date 2026-04: Value 382M USD
- Date 2026-05: Value 350M USD
- Date 2026-06: Value 432M USD
- Date 2026-07: Value 400M USD
Top destinations
- Germany23B
- United States13.5B
- France9.5B
- Italy8.5B
- Sweden8B
- Australia6.7B
- United Kingdom5.9B
- Japan5.2B
- Switzerland3.5B
- Ireland2.9B
Top destinations
- Germany: 23,032,000,000 USD
- United States: 13,539,000,000 USD
- France: 9,534,000,000 USD
- Italy: 8,456,000,000 USD
- Sweden: 7,990,000,000 USD
- Australia: 6,680,000,000 USD
- United Kingdom: 5,913,000,000 USD
- Japan: 5,192,000,000 USD
- Switzerland: 3,452,000,000 USD
- Ireland: 2,890,000,000 USD
Key findings
Largest import market
23.03B USD
Germany · last 8 years
Fastest demand growth
84,913.74
Montenegro · last 8 years
Highest unit price
$2,523.67 /kg
Sweden · +21,722.17% vs avg
Turn this market into qualified conversations.
Your agent contacts, compares, and screens the suppliers that fit.
Insights
Product insights to guide your sourcing.
Product Trends
Topical semi-solid formulations, especially hydrogels and micro-emulsions for acne and eczema, see steady growth in sourcing. Gels with transdermal absorption like liposomes are also highly sought after.
Industrial Cluster Analysis
Dermatological drug contract manufacturing is concentrated in the Yangtze River Delta (Jiangsu, Zhejiang) and Guangdong. These clusters offer advanced GMP-compliant lines suited for high-quality topical formulations.
Quality Expectations
Target markets demand strict formulation stability, active ingredient consistency, and zero microbial contamination. Topicals must maintain viscosity and homogeneity across temperature variations over their shelf life.
What You Need to Know
Request Certificates of Analysis (COAs), GMP audit reports, stability data, and microbial test results. Order pilot batch samples to verify formulation viscosity, skin absorption, and tube sealing integrity.
MOQ for custom topicals typically ranges from 10,000 to 30,000 tubes. Production takes 45 to 60 days, driven by active ingredient sourcing, rigorous microbiological testing, and specialized GMP cleanroom scheduling.
Budget for regulatory registration fees, formulation stability or bioequivalence testing, custom packaging print molds, third-party pre-shipment quality audits, and specialized temperature-controlled logistics.
